Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer

The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer

FromSurgOnc Today®


The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer

FromSurgOnc Today®

ratings:
Length:
30 minutes
Released:
May 8, 2020
Format:
Podcast episode

Description

In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma
Released:
May 8, 2020
Format:
Podcast episode

Titles in the series (99)

SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO.